Codiak BioSciences, Inc. (CDAK)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

35 CAMBRIDGEPARK DRIVE CAMBRIDGE, MA 02140

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of diseases, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.

Data as of 2021-07-19 10:07:45 -0400
Market Cap352.261 Million Shares Outstanding22.044 Million Avg 30-day Volume175.453 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.71 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low37.85 / 7.9 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -39.5223
Data provided by IEX Cloud
View SEC Filings from CDAK instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 48 48 0.0% 13 (0.76%) 15 (0.87%) -13.33%
13F shares: 12.546 Million 9.792 Million 28.13% 1.813 Million 1.358 Million 33.47%
% Ownership 57.044 52.1727 9.34% 8.2437 7.2383 13.89%
New Positions: 8 47 -82.98% 3 15 -80.0%
Increased Positions 16 4
Closed Positions 8 5
Reduced Positions 11 1
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CDAK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CDAK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COONEY CHARLES L

  • Director
10,000 2021-06-18 3

MELAS KYRIAZI THEO

  • Director
10,000 2021-06-18 4

GILLIS STEVEN

  • Director
10,000 2021-06-18 4

BERNSTEIN KAREN

  • Director
10,000 2021-06-18 3

HADDOCK JASON

  • Director
10,000 2021-06-18 4

SATHYANARAYANAN SRIRAM CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-06-09 2

EGGIMANN ANNE-VIRGINIE

  • Director
20,000 2021-05-17 2

WHELER JENNIFER J. CHIEF MEDICAL OFFICER

  • Officer
0 2021-05-10 2

MORRISON BRIGGS

  • Director
4,761 2021-02-17 3

WILLIAMS DOUGLAS E PRESIDENT & CEO

  • Officer
  • Director
0 2021-01-22 3

BAIN LINDA CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-22 2

BRUDNICK RICHARD SEE REMARKS

  • Officer
0 2021-01-22 2

BARNA NICOLE SEE REMARKS

  • Officer
0 2021-01-22 2

KONSTANTINOV KONSTANTIN SEE REMARKS

  • Officer
0 2021-01-22 2

VERMA AJAY SEE REMARKS

  • Officer
0 2021-01-22 2

HOWZE YALONDA SEE REMARKS

  • Officer
0 2021-01-22 2

SORENSEN BENNY SEE REMARKS

  • Officer
0 2021-01-22 2

ARCH VENTURE FUND VIII, L.P.

ARCH VENTURE FUND VIII OVERAGE, L.P.

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

ARCH VENTURE PARTNERS VIII, LLC

ARCH VENTURE PARTNERS VIII, L.P.

  • 10% Owner
3,854,098 2020-10-16 2

ALASKA PERMANENT FUND CORP

18,051,580 2020-10-16 2

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND V, L.P.

FLAGSHIP V VENTURELABS RX FUND, L.P.

AFEYAN NOUBAR

  • 10% Owner
2,607,303 2020-10-16 2

LANDER ERIC S

  • Director
0 2020-10-13 2

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC

FLAGSHIP VENTURELABS V LLC

FLAGSHIP VENTURELABS V MANAGER LLC

FLAGSHIP PIONEERING INC.

FLAGSHIP VENTURES FUND V, L.P.

FLAGSHIP V VENTURELABS RX FUND, L.P.

AFEYAN NOUBAR

  • 10% Owner
485,949 2020-10-13 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MELAS KYRIAZI THEO - Director

2021-06-22 19:08:06 -0400 2021-06-18 A 10,000 a 10,000 direct

BERNSTEIN KAREN - Director

2021-06-22 19:17:00 -0400 2021-06-18 A 10,000 a 10,000 direct

GILLIS STEVEN - Director

2021-06-22 19:10:21 -0400 2021-06-18 A 10,000 a 10,000 direct

COONEY CHARLES L - Director

2021-06-22 19:14:01 -0400 2021-06-18 A 10,000 a 10,000 direct

HADDOCK JASON - Director

2021-06-22 19:09:12 -0400 2021-06-18 A 10,000 a 10,000 direct

SATHYANARAYANAN SRIRAM - Officer CHIEF SCIENTIFIC OFFICER

2021-06-22 19:06:53 -0400 2021-06-09 A 40,000 a 40,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CODIAK BIOSCIENCES INC CDAK 2021-07-23 22:15:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 21:45:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 21:15:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 20:45:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 20:15:05 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 19:45:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 19:15:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 18:45:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 18:15:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 17:45:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 17:15:02 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 16:45:02 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 16:15:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 15:45:02 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 15:15:03 UTC -0.9172 0.9972 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 14:45:03 UTC -0.9908 1.0708 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 14:15:03 UTC -0.9908 1.0708 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 13:45:03 UTC -0.9908 1.0708 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 13:15:03 UTC -0.9908 1.0708 50000
CODIAK BIOSCIENCES INC CDAK 2021-07-23 12:45:03 UTC -0.9908 1.0708 75000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments